»ÆÉ«Ö±²¥

REMINDER: Applications close on Thursday January 21^st 2016 at 2:00pm EST for the Weston Brain Institute’s Transformational Research 2016 program.

For more information about this program, .Ìý

To apply for this opportunity, submit a Letter of Intent through our online grants management system .

Goal
To provide funding for preclinical translational research that will accelerate the development of therapeutics for neurodegenerative diseases of aging.

Funding
A maximum of $1,500,000 over up to 3 years.

Eligibility
Researchers at or above the level of Assistant Professor or equivalent are eligible to apply as the Principal Applicant. Collaborators must be at the post-doctoral level or above.

Disease scope
All the Institute’s neurodegenerative diseases of aging are covered by this program (see ) with the exception of amyotrophic lateral sclerosis (ALS).
New for 2016: projects focused on ALS should be submitted to the ALS-focused program scheduled to launch in Spring 2016.

Development scope
Development of a therapeutic and/or a tool that helps to accelerate the development of therapeutics for neurodegenerative diseases of aging.

We welcome any inquiries about this and any other funding opportunities to neuro@weston.ca or 416-935-4056.